Andere talen HilleVax, Inc.

Aandelen

HLVX

US43157M1027

Geschatte realtime Cboe BZX Andere beurzen 16:33:38 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
12,74 ^USD	-0,51%		+2,39%	-20,06%

05/04	Hillevax Insider verkocht aandelen ter waarde van $264.467, volgens een recente SEC filing	MT
21/03	HILLEVAX, INC. : Stifel Nicolaus bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hillevax Insider Sold Shares Worth $264,467, According to a Recent SEC Filing	05/04
HilleVax Insider Sold Shares Worth $985,536,428, According to a Recent SEC Filing	21/03
HilleVax Proposes $500 Million Offering of Equity, Debt Securities in Shelf Registration	20/03
HilleVax Q4 Net Loss Widens; Shares Extend Decline After Hours	20/03
HilleVax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
HilleVax, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/03
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress	20/03
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference	05/02
HilleVax Names New Chief Operating Officer	18/01
HilleVax Taps Sean McLoughlin as Chief Operating Officer	18/01
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer	18/01
HilleVax, Inc. Announces Executive Changes	18/01
Kanghua Biological Products Licenses Norovirus Vaccine to HilleVax	09/01
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China	08/01
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China	08/01
HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01
Certain Options of HilleVax, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023.	19/12
Certain Restricted Stock Units of HilleVax, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023.	19/12
Certain Common Stock of HilleVax, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023.	19/12
HilleVax, Inc.(NasdaqGS:HLVX) dropped from NASDAQ Biotechnology Index	15/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen HilleVax, Inc.

Aandelen

HLVX

US43157M1027

Andere talen

Filters